Ipamorelin and CJC-1295Â are amongst the most heavily researched growth hormone secretagogues. While ipamorelin acts at the ghrelin receptor, CJC-1295 acts at the growth hormone releasing hormone (GHRH) receptor. This fact alone makes the combination of these peptides popular in research investigating how both high and widened growth hormone (GH) peaks might work synergistically to produce enhanced effects while limiting side effects. Fortunately, the Ipamorelin/CJC-1295 cost point remains low because both peptides are well established and therefore affordable.
